Want to see JP:4882 full AI Analyst Report?
4882 Stock Chart & Stats
¥220.00
-¥14.00(-2.34%)
At close: 4:00 PM EST
¥220.00
-¥14.00(-2.34%)
Day’s Range― - ―
52-Week Range¥134.00 - ¥361.00
Previous CloseN/A
Volume686.20K
Average Volume (3M)226.58K
Market Cap
¥2.73B
Enterprise Value¥1.13K
Total Cash (Recent Filing)¥1.52B
Total Debt (Recent Filing)¥0.00
Price to Earnings (P/E)―
Beta1.54
Next Earnings
Nov 12, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-48.18
Shares Outstanding18,429,500
10 Day Avg. Volume184,610
30 Day Avg. Volume226,583
Financial Highlights & Ratios
PEG Ratio0.19
Price to Book (P/B)2.69
Price to Sales (P/S)24.20
P/FCF Ratio-4.95
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-62.5
Revenue Forecast (FY)¥120.00M
Bulls Say, Bears Say
Bulls Say
Sustained Revenue GrowthRevenue has approximately doubled over five years, indicating expanding commercial activity and product adoption. Continued top-line growth provides a foundation for operating leverage if the company can control development and operating costs.
Debt-Free Balance SheetThe absence of reported debt limits interest burden, refinancing exposure, and creditor pressure. Positive equity and a substantial asset base provide more financial flexibility than a highly leveraged structure while the company works toward profitability.
Strong Gross Profit Relative To SalesStrong gross profitability suggests the underlying products or services may retain meaningful economic value before operating expenses. This creates potential for improved earnings as revenue scales, provided research and administrative spending becomes more efficient.
Bears Say
Persistent Operating LossesLarge recurring operating and net losses show that revenue growth has not yet translated into a viable earnings model. Continued losses can restrict strategic flexibility and require management to achieve substantial cost reductions or commercial scale.
Ongoing Cash BurnPersistent negative operating and free cash flow means the business consumes cash to operate rather than funding itself internally. Even with recent improvement, continued burn may create dependence on external financing and constrain investment capacity.
Material Equity ErosionThe substantial decline in equity reflects the cumulative effect of ongoing losses and weak returns. This reduces the balance-sheet cushion available to absorb future setbacks and signals that shareholder value has been eroded while commercialization remains incomplete.
Perseus Proteomics, Inc. News
4882 FAQ
What was Perseus Proteomics, Inc.’s price range in the past 12 months?
Perseus Proteomics, Inc. lowest stock price was ¥134.00 and its highest was ¥361.00 in the past 12 months.
What is Perseus Proteomics, Inc.’s market cap?
Perseus Proteomics, Inc.’s market cap is ¥2.73B.
When is Perseus Proteomics, Inc.’s upcoming earnings report date?
Perseus Proteomics, Inc.’s upcoming earnings report date is Nov 12, 2026 which is in 82 days.
How were Perseus Proteomics, Inc.’s earnings last quarter?
Perseus Proteomics, Inc. released its earnings results on Aug 13, 2026. The company reported -¥11.85 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.
Is Perseus Proteomics, Inc. overvalued?
According to Wall Street analysts Perseus Proteomics, Inc.’s price is currently Overvalued.
Does Perseus Proteomics, Inc. pay dividends?
Perseus Proteomics, Inc. does not currently pay dividends.
What is Perseus Proteomics, Inc.’s EPS estimate?
Perseus Proteomics, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Perseus Proteomics, Inc. have?
Perseus Proteomics, Inc. has 18,429,500 shares outstanding.
What happened to Perseus Proteomics, Inc.’s price movement after its last earnings report?
Perseus Proteomics, Inc. reported an EPS of -¥11.85 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 2.797%.
Which hedge fund is a major shareholder of Perseus Proteomics, Inc.?
Currently, no hedge funds are holding shares in JP:4882
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Perseus Proteomics, Inc.
null
Technical Analysis
Trans Genic Inc.
―
Cosmo Bio Co., Ltd.
―
ReproCELL Inc.
―
Human Metabolome Technologies, Inc.
―
Precision System Science Co.,Ltd
―